We are just past the halfway point of the trading yearIt has been a decent one for investors so far, especially in comparison to Europe and China, but not nearly as good as 2017 to this pointThe small biotech sector has performed well despite what has been a somewhat lackluster M&A marketSmall and mid-cap biotech stocks have risen in the mid-teens...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.